Mouse studies targeting Csnk1a1 demonstrated that although haplo‐insufficiency for CSNK1A1 promotes HSC expansion, in line with the competitive advantage of del(5q) MDS stem cells, homozygous deletion of Csnk1a1 results in HSC failure [128]. This evidence concerns the gene CSNK1A1 and myelodysplastic syndrome.